Effect of the Antidiabetic Drug Dapagliflozin on the Coronary Macrovascular and Microvascular Function in Type 2 Diabetic Patients
Clinical trial NCT05392959 · TERMINATED
Trial details
- NCT number
- NCT05392959
- Sponsor
- Centre Hospitalier Universitaire Saint Pierre
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-06
- Primary completion
- 2023-07-17
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.